165 related articles for article (PubMed ID: 18253699)
1. Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients.
Wolff JE; Berrak S; Koontz Webb SE; Zhang M
J Neurooncol; 2008 May; 88(1):57-63. PubMed ID: 18253699
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of mustoforan in management of malignant glioma].
Kobiakov GL
Vopr Onkol; 2007; 53(6):724-9. PubMed ID: 18416147
[No Abstract] [Full Text] [Related]
3. Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.
Papavero L; Loew F; Jaksche H
Acta Neurochir (Wien); 1987; 85(3-4):128-37. PubMed ID: 3035882
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU.
Tonn JC; Schönmayr R; Kraemer HP
J Neurooncol; 1990 Feb; 8(1):41-5. PubMed ID: 2319289
[TBL] [Abstract][Full Text] [Related]
5. ACNU-based chemotherapy for recurrent glioma in the temozolomide era.
Happold C; Roth P; Wick W; Steinbach JP; Linnebank M; Weller M; Eisele G
J Neurooncol; 2009 Mar; 92(1):45-8. PubMed ID: 18987781
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
7. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
8. Single-agent chemotherapy of brain tumors. A five-year review.
Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
[TBL] [Abstract][Full Text] [Related]
9. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.
Rajan B; Ross G; Lim CC; Ashley S; Goode D; Traish D; Brada M
Eur J Cancer; 1994; 30A(12):1809-15. PubMed ID: 7880611
[TBL] [Abstract][Full Text] [Related]
10. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
11. [Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months].
Paillas JE; Prince MA; Hassoun J; Pellet W; Peragut JC
Rev Neurol (Paris); 1979 Mar; 135(3):251-62. PubMed ID: 227020
[No Abstract] [Full Text] [Related]
12. Adjuvant nitrosourea therapy for glioblastoma.
Brisman R; Housepian EM; Chang C; Duffy P; Balis E
Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial.
Chang SM; Prados MD; Yung WK; Fine H; Junck L; Greenberg H; Robins HI; Mehta M; Fink KL; Jaeckle KA; Kuhn J; Hess K; Schold C
Cancer; 2004 Apr; 100(8):1712-6. PubMed ID: 15073861
[TBL] [Abstract][Full Text] [Related]
14. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
16. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Buckner JC; Schomberg PJ; McGinnis WL; Cascino TL; Scheithauer BW; O'Fallon JR; Morton RF; Kuross SA; Mailliard JA; Hatfield AK; Cole JT; Steen PD; Bernath AM
Cancer; 2001 Jul; 92(2):420-33. PubMed ID: 11466698
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305).
Shibui S; Narita Y; Mizusawa J; Beppu T; Ogasawara K; Sawamura Y; Kobayashi H; Nishikawa R; Mishima K; Muragaki Y; Maruyama T; Kuratsu J; Nakamura H; Kochi M; Minamida Y; Yamaki T; Kumabe T; Tominaga T; Kayama T; Sakurada K; Nagane M; Kobayashi K; Nakamura H; Ito T; Yazaki T; Sasaki H; Tanaka K; Takahashi H; Asai A; Todo T; Wakabayashi T; Takahashi J; Takano S; Fujimaki T; Sumi M; Miyakita Y; Nakazato Y; Sato A; Fukuda H; Nomura K
Cancer Chemother Pharmacol; 2013 Feb; 71(2):511-21. PubMed ID: 23228988
[TBL] [Abstract][Full Text] [Related]
18. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
19. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
20. Imaging response in malignant glioma, RTOG 90-06.
Lustig RA; Seiferheld W; Berkey B; Yung AW; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
Am J Clin Oncol; 2007 Feb; 30(1):32-7. PubMed ID: 17278892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
